BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15809479)

  • 1. Imaging glioma extent with 131I-TM-601.
    Hockaday DC; Shen S; Fiveash J; Raubitschek A; Colcher D; Liu A; Alvarez V; Mamelak AN
    J Nucl Med; 2005 Apr; 46(4):580-6. PubMed ID: 15809479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma.
    Mamelak AN; Rosenfeld S; Bucholz R; Raubitschek A; Nabors LB; Fiveash JB; Shen S; Khazaeli MB; Colcher D; Liu A; Osman M; Guthrie B; Schade-Bijur S; Hablitz DM; Alvarez VL; Gonda MA
    J Clin Oncol; 2006 Aug; 24(22):3644-50. PubMed ID: 16877732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?
    Pöpperl G; Kreth FW; Herms J; Koch W; Mehrkens JH; Gildehaus FJ; Kretzschmar HA; Tonn JC; Tatsch K
    J Nucl Med; 2006 Mar; 47(3):393-403. PubMed ID: 16513607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
    J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 123I-2-iodo-tyrosine, a new tumour imaging agent: human biodistribution, dosimetry and initial clinical evaluation in glioma patients.
    Keyaerts M; Lahoutte T; Neyns B; Caveliers V; Vanhove C; Everaert H; Kersemans K; Franken PR; Mertens J; Bossuyt A
    Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):994-1002. PubMed ID: 17237962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with 89Zr-Fresolimumab PET.
    den Hollander MW; Bensch F; Glaudemans AW; Oude Munnink TH; Enting RH; den Dunnen WF; Heesters MA; Kruyt FA; Lub-de Hooge MN; Cees de Groot J; Pearlberg J; Gietema JA; de Vries EG; Walenkamp AM
    J Nucl Med; 2015 Sep; 56(9):1310-4. PubMed ID: 26135113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601).
    Mamelak AN; Jacoby DB
    Expert Opin Drug Deliv; 2007 Mar; 4(2):175-86. PubMed ID: 17335414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing mice.
    Shen S; Khazaeli MB; Gillespie GY; Alvarez VL
    J Neurooncol; 2005 Jan; 71(2):113-9. PubMed ID: 15690125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
    Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
    J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-sestamibi brain SPECT after chemoradiotherapy is prognostic of survival in patients with high-grade glioma.
    Beauchesne P; Pedeux R; Boniol M; Soler C
    J Nucl Med; 2004 Mar; 45(3):409-13. PubMed ID: 15001680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
    Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
    Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
    Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
    J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution and internal dosimetry of the 188Re-labelled humanized monoclonal antibody anti-epidemal growth factor receptor, nimotuzumab, in the locoregional treatment of malignant gliomas.
    Torres LA; Coca MA; Batista JF; Casaco A; Lopez G; García I; Perera A; Peña Y; Hernández A; Sanchez Y; Romero S; Leyva R; Prats A; Fernandez R
    Nucl Med Commun; 2008 Jan; 29(1):66-75. PubMed ID: 18049099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunodetection of gliomas by administration of radiolabelled monoclonal antibodies. Experimental data.
    Stavrou D; Mellert W; Bilzer T; Senekowitsch R; Keiditsch E; Mehraein P
    Anticancer Res; 1985; 5(2):147-56. PubMed ID: 3994308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation for degree of malignancy and prognosis of patients with brain glioma using 99Tcm-MIBI brain SPECT].
    Fan YX; Luo RC; Li GP; Zheng H; Huang K
    Ai Zheng; 2004 Jun; 23(6):689-92. PubMed ID: 15191672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.
    Grosu AL; Weber WA; Riedel E; Jeremic B; Nieder C; Franz M; Gumprecht H; Jaeger R; Schwaiger M; Molls M
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):64-74. PubMed ID: 16111573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of a standardized multimodality image protocol for navigation-guided surgery of suspected low-grade gliomas.
    Mert A; Kiesel B; Wöhrer A; Martínez-Moreno M; Minchev G; Furtner J; Knosp E; Wolfsberger S; Widhalm G
    Neurosurg Focus; 2015 Jan; 38(1):E4. PubMed ID: 25552284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classic tumour imaging agents for glioma evaluation: 99mTc-tetrofosmin.
    Alexiou GA; Tsiouris S; Kyritsis AP; Polyzoidis KS; Fotopoulos AD
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2143-4. PubMed ID: 17891392
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase 1 Safety, Pharmacokinetics, and Fluorescence Imaging Study of Tozuleristide (BLZ-100) in Adults With Newly Diagnosed or Recurrent Gliomas.
    Patil CG; Walker DG; Miller DM; Butte P; Morrison B; Kittle DS; Hansen SJ; Nufer KL; Byrnes-Blake KA; Yamada M; Lin LL; Pham K; Perry J; Parrish-Novak J; Ishak L; Prow T; Black K; Mamelak AN
    Neurosurgery; 2019 Oct; 85(4):E641-E649. PubMed ID: 31069381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPECT imaging and radionuclide therapy of glioma using
    Qiao W; Zhao L; Wu S; Liu C; Guo L; Xing Y; Zhao J
    J Neurooncol; 2017 Jun; 133(2):287-295. PubMed ID: 28488065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.